Status: Not yet recruiting
Phase IIa Trial of Oral SSS17 for Post-Arthroplasty Anemia
To assess the safety, tolerability, efficacy, and pharmacokinetic/pharmacodynamic (PK/PD) characteristics of orally administered SSS17 capsules in patients with postoperative anemia following elective total hip or knee arthroplasty.
Participants needed: 90
Trial details
Phase: Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: Shenyang Sunshine Pharmaceutical Co., LTD.Updated: Jun 11, 2025Locations: 1
Eligibility criteria
Signed informed consent obtained [+4]
Hypersensitivity to the investigational product or any of its components [+16]